ARE · Q4 2025 Earnings

The South San Francisco exit is the operational expression of a structural-supply view, not a cyclical one. Mark detailed the Gateway Campus sale explicitly: "we decided to exit this investment given the challenging supply and demand dynamics in South San Francisco and the very significant capital required over time to redevelop the campus." Combined with the 88 Bluxome Street SoMa exit (the only ARE asset in that submarket), the message is that selected submarkets are being abandoned rather than waited out. This is a shift from prior-quarter framing of cyclical bottoming toward acknowledgment that supply pressure in certain markets won't resolve on a manageable timeline.

Two quarters ago public biotech was the demand mainstay; this quarter it is an absent catalyst. In Q2 Hallie emphasized "$22 billion deployed" in venture funding; in Q3 management still anchored to venture funding as constructive; this quarter the tone shifted to acknowledging that "venture funds have raised the lowest amount of dollars in the last decade...companies are very conservative" and that "we really need to see the public biotech sector contribute." The IPO window remains closed and follow-on financings are going to non-expansion-stage names. Public biotech has moved from "mainstay continuing" to "gap requiring external catalysts."

The development pipeline narrative has evolved from "review for lower-cost alternatives" to "potentially pause or sell." In Q2 Mark introduced cost re-evaluation of 2027 projects; in Q3 he framed pipeline contraction from 20% toward 10–15% of assets as a structural pivot; this quarter he was explicit on four specific under-construction projects: "To the extent that we decide in the future to either pause or sell any of those projects, capitalization of interest would cease." The 2026 capitalized interest guide of $225M–$275M is now conditional on decisions due by May 2026. This is no longer pipeline trimming — it is selective abandonment.

Leasing volume framing inverted from validation to insufficient. Q2 framed leasing as "consolidation-driven brand vindication"; Q3 acknowledged demand softness; this quarter Mark flagged "393,000 rentable square feet [vacant space] was almost double the quarterly average" — strong volume — but paired it with elevated free rent and rental rate pressure. Peter added: "significant amount of free rent in order to win the deal." Management is now explicitly trading near-term rent economics for occupancy, with the bet that free rent burns off into future income. That defers the earnings recovery further.

The 2026 guide is being framed as a managed trough, not an uncertain bottom. The explicit disclosure of Q4 2026 FFO/share at $1.40–$1.60 as "the trough" is a tone shift toward telegraphed predictability — management is committing to a floor and a re-acceleration shape (H2 2026 occupancy recovery, normalized leverage by year-end). Whether the trough holds depends on dispositions executing at guided pricing and the four pipeline projects getting resolved without further capitalized interest cliffs.